K Pharma,Inc. Statistics
Total Valuation
K Pharma,Inc. has a market cap or net worth of JPY 7.85 billion. The enterprise value is 7.44 billion.
Important Dates
The last earnings date was Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
K Pharma,Inc. has 11.62 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 11.62M |
| Shares Outstanding | 11.62M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 40.90% |
| Owned by Institutions (%) | 4.88% |
| Float | 1.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 19.03 |
| P/TBV Ratio | 19.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.53, with a Debt / Equity ratio of 3.88.
| Current Ratio | 13.53 |
| Quick Ratio | 12.66 |
| Debt / Equity | 3.88 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.77 |
Financial Efficiency
Return on equity (ROE) is -116.19% and return on invested capital (ROIC) is -34.99%.
| Return on Equity (ROE) | -116.19% |
| Return on Assets (ROA) | -32.38% |
| Return on Invested Capital (ROIC) | -34.99% |
| Return on Capital Employed (ROCE) | -49.01% |
| Weighted Average Cost of Capital (WACC) | 5.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -57.95M |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, K Pharma,Inc. has paid 2.00 million in taxes.
| Income Tax | 2.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.94% in the last 52 weeks. The beta is 0.48, so K Pharma,Inc.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +3.94% |
| 50-Day Moving Average | 744.52 |
| 200-Day Moving Average | 740.32 |
| Relative Strength Index (RSI) | 46.83 |
| Average Volume (20 Days) | 27,895 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.01B |
| Pretax Income | -1.16B |
| Net Income | -1.16B |
| EBITDA | n/a |
| EBIT | -1.01B |
| Earnings Per Share (EPS) | -99.76 |
Full Income Statement Balance Sheet
The company has 2.03 billion in cash and 1.62 billion in debt, with a net cash position of 401.00 million or 34.50 per share.
| Cash & Cash Equivalents | 2.03B |
| Total Debt | 1.62B |
| Net Cash | 401.00M |
| Net Cash Per Share | 34.50 |
| Equity (Book Value) | 419.00M |
| Book Value Per Share | 36.05 |
| Working Capital | 2.01B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -1.01 billion and capital expenditures -34.00 million, giving a free cash flow of -1.05 billion.
| Operating Cash Flow | -1.01B |
| Capital Expenditures | -34.00M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 1.63B |
| Free Cash Flow | -1.05B |
| FCF Per Share | -90.08 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
K Pharma,Inc. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | -0.11% |
| Earnings Yield | -14.78% |
| FCF Yield | -13.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |